Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Lifecore Biomedical (LFCR) Tax Provisions: 2009-2025

Historic Tax Provisions for Lifecore Biomedical (LFCR) over the last 16 years, with May 2025 value amounting to $43,000.

  • Lifecore Biomedical's Tax Provisions rose 157.89% to $33,000 in Q2 2025 from the same period last year, while for May 2025 it was $43,000, marking a year-over-year decrease of 76.50%. This contributed to the annual value of $43,000 for FY2025, which is 76.50% down from last year.
  • According to the latest figures from FY2025, Lifecore Biomedical's Tax Provisions is $43,000, which was down 76.50% from $183,000 recorded in FY2024.
  • In the past 5 years, Lifecore Biomedical's Tax Provisions ranged from a high of $308,000 in FY2023 and a low of -$6.3 million during FY2021.
  • In the last 3 years, Lifecore Biomedical's Tax Provisions had a median value of $183,000 in 2024 and averaged $178,000.
  • As far as peak fluctuations go, Lifecore Biomedical's Tax Provisions surged by 105.91% in 2023, and later slumped by 76.50% in 2025.
  • Lifecore Biomedical's Tax Provisions (Yearly) stood at -$6.3 million in 2021, then rose by 17.94% to -$5.2 million in 2022, then surged by 105.91% to $308,000 in 2023, then crashed by 40.58% to $183,000 in 2024, then slumped by 76.50% to $43,000 in 2025.